Dermatology NewsBrodalumab suicide risk similar to other biologics, postmarket study findsSeptember 19, 2022PsoriasisPsoriatic ArthritisMixed Topics
Dermatology NewsSustained response at 2 years reported for newly approved oral psoriasis agentSeptember 15, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsFDA approves oral TYK2 inhibitor deucravacitinib for treating psoriasisSeptember 12, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsShould patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?September 8, 2022Psoriatic ArthritisPsoriasis
Dermatology NewsInhaled, systemic steroids linked to changes in brain structureAugust 31, 2022Autoimmune DiseasesMixed TopicsPsoriatic Arthritis
Dermatology NewsAutoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depthAugust 29, 2022COVID-19 UpdatesPsoriatic ArthritisPsoriasisInfectious Diseases
Dermatology NewsAsian patients with psoriasis have shortest visits, study showsAugust 24, 2022PsoriasisPsoriatic ArthritisDiversity in Medicine
Dermatology NewsFDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration formAugust 17, 2022Psoriatic ArthritisPediatricsPsoriasis
Dermatology NewsBiosimilar-to-biosimilar switches deemed safe and effective, systematic review revealsAugust 15, 2022Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
Dermatology NewsStudy suggests psoriasis and PsA are underdiagnosed in underserved groupsAugust 12, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsUstekinumab becomes second biologic approved for PsA in kidsAugust 3, 2022Psoriatic ArthritisPediatricsRare Diseases
Dermatology NewsTopical roflumilast approved for psoriasis in adults and adolescentsAugust 1, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsQuestionnaire for patients with psoriasis might identify risk of axial involvementJuly 26, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsNAFLD strongly correlated with psoriasis, PsA; risk linked to severityJuly 20, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsMethotrexate’s impact on COVID-19 vaccination: New insights madeJuly 19, 2022COVID-19 UpdatesPsoriatic ArthritisAtopic DermatitisPsoriasis